Manage episode 481599964 series 3361449
Flagship Pioneering doesn't go out to find the next big thing in biotech when investing their billions in fund capital - instead, they take a different route.
Flagship Pioneering has founded more than 100 companies in the life sciences worth in total an estimated $75 billion. With a proven model for biotech startup success and a culture designed to surface new and interesting ideas, Flagship offers a different approach to biotech funding that is paying off time and again.
In this episode I talk with Lovisa Afzelius, a General Partner at Flagship, uncover the ways in which Flagship is shaking up the biotech funding model, and come to understand the reasons why others will have a hard time imitating its success.
This episode is brought to you by Jubilant Biosys.
01:52 Meet Lovisa Afzelius
03:37 Learning lessons in big pharma
04:56 From top pharma to startup biotech
07:23 Two different worlds and ways of thinking
08:29 Flagship Pioneering
13:39 Finding the right people
18:13 Deploying capital to create value
21:06 Expanding into new markets
21:55 How does the Flagship model identify disruptors so well?
24:20 Why don’t others emulate the Flagship model?
25:36 Building a culture of ‘yes, and…’
27:47 Learning from the companies that don’t succeed
30:49 Artificial intelligence and biology
35:19 Lessons from business that never found market fit
37:29 The future for Flagship
39:55 The importance of diversity in biotech
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
To dive deeper into the topic:
Chapters
1. Inside Flagship Pioneering's strategy: How this VC turns ideas into biotech giants (00:00:00)
2. Meet Lovisa Afzelius (00:01:52)
3. Learning lessons in big pharma (00:03:37)
4. From top pharma to startup biotech (00:04:56)
5. Two different worlds and ways of thinking (00:07:23)
6. Flagship Pioneering (00:08:29)
7. Finding the right people (00:13:39)
8. Deploying capital to create value (00:18:13)
9. Expanding into new markets (00:21:06)
10. How does the Flagship model identify disruptors so well? (00:21:55)
11. Why don’t others emulate the Flagship model? (00:24:20)
12. Building a culture of ‘yes, and…’ (00:25:36)
13. Learning from the companies that don’t succeed (00:27:47)
14. Artificial intelligence and biology (00:30:49)
15. Lessons from business that never found market fit (00:35:19)
16. The future for Flagship (00:37:29)
17. The importance of diversity in biotech (00:39:55)
173 episodes